Semler Scientific, Inc. (SMLR)
- Previous Close
29.87 - Open
29.82 - Bid 28.86 x 100
- Ask 29.21 x 100
- Day's Range
29.10 - 30.49 - 52 Week Range
20.88 - 53.38 - Volume
210,363 - Avg. Volume
140,069 - Market Cap (intraday)
205.828M - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
10.48 - EPS (TTM)
2.78 - Earnings Date Aug 8, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
40.00
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
www.semlerscientific.comRecent News: SMLR
Performance Overview: SMLR
Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SMLR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SMLR
Valuation Measures
Market Cap
205.83M
Enterprise Value
143.21M
Trailing P/E
10.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.44
Price/Book (mrq)
2.64
Enterprise Value/Revenue
2.17
Enterprise Value/EBITDA
5.88
Financial Highlights
Profitability and Income Statement
Profit Margin
32.92%
Return on Assets (ttm)
19.23%
Return on Equity (ttm)
31.18%
Revenue (ttm)
65.88M
Net Income Avi to Common (ttm)
21.69M
Diluted EPS (ttm)
2.78
Balance Sheet and Cash Flow
Total Cash (mrq)
62.75M
Total Debt/Equity (mrq)
0.18%
Levered Free Cash Flow (ttm)
15.92M
Research Analysis: SMLR
Company Insights: SMLR
SMLR does not have Company Insights